Literature DB >> 11651973

Protecting human subjects from harm through improved risk judgments.

Eric M Meslin.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  1990        PMID： 11651973

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  6 in total

Review 1.  Ethical considerations in neuroclinical trials.

Authors:  S N Macciocchi; W A Alves
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

2.  The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study.

Authors:  H E M van Luijn; N K Aaronson; R B Keus; A W Musschenga
Journal:  J Med Ethics       Date:  2006-03       Impact factor: 2.903

3.  The Role of Intuition in Risk/Benefit Decision-Making in Human Subjects Research.

Authors:  David B Resnik
Journal:  Account Res       Date:  2016-06-13       Impact factor: 2.622

4.  Standards of evidence for institutional review board decision-making.

Authors:  David B Resnik
Journal:  Account Res       Date:  2020-12-08       Impact factor: 3.057

5.  Role of Pharmacovigilance in India: An overview.

Authors:  Sanvidhan G Suke; Prabhat Kosta; Harsh Negi
Journal:  Online J Public Health Inform       Date:  2015-07-01

6.  Ethical issues in clinical research.

Authors:  Vasantha Muthuswamy
Journal:  Perspect Clin Res       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.